title: Cutting edge: C3, a key component of complement activation, is not required for the development of myelin oligodendrocyte glycoprotein peptide-induced experimental autoimmune encephalomyelitis in mice.
abstract: Experimental autoimmune encephalomyelitis (EAE), an inflammatory demyelinating disease of the CNS, is regarded as an experimental model for multiple sclerosis. The complement has been implicated in the pathogenesis of multiple sclerosis. To clarify the role of C in mouse EAE, we immunized mice deficient in C3 (C3(-/-)) and their wild-type (C3(+/+)) littermates with myelin oligodendrocyte glycoprotein peptide 35-55. C3(-/-) mice were susceptible to EAE as much as the C3(+/+) mice were. No differences were found for the production of IL-2, IL-4, IL-12, TNF-alpha, and IFN-gamma between C3(+/+) and C3(-/-) mice. This finding shows that C3, a key component in C activation, is not essential in myelin oligodendrocyte glycoprotein peptide-induced EAE in mice.
authors.affiliation: Department of Neurology, Department of Pathology and Laboratory Medicine, Division of Neuropathology, University of Pennsylvania, Philadelphia, PA 19104, USA.
authors.forename: D M
authors.initials: DM
authors.lastname: Calida
authors.forename: C
authors.initials: C
authors.lastname: Constantinescu
authors.forename: E
authors.initials: E
authors.lastname: Purev
authors.forename: G X
authors.initials: GX
authors.lastname: Zhang
authors.forename: E S
authors.initials: ES
authors.lastname: Ventura
authors.forename: E
authors.initials: E
authors.lastname: Lavi
authors.forename: A
authors.initials: A
authors.lastname: Rostami
mesh_terms: D000818:Animals; D002474:Cell-Free System; D002478:Cells, Cultured; D003167:Complement Activation / Q000235:genetics; D003176:Complement C3 / Q000096:biosynthesis / Q000172:deficiency / Q000235:genetics / Q000502:physiology*; D016207:Cytokines / Q000032:analysis / Q000378:metabolism; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000235:genetics / Q000276:immunology* / Q000473:pathology; D007150:Immunohistochemistry; D007279:Injections, Subcutaneous; D018664:Interleukin-12 / Q000032:analysis / Q000096:biosynthesis; D008198:Lymph Nodes / Q000737:chemistry / Q000166:cytology / Q000276:immunology; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D009185:Myelin Proteins; D018992:Myelin-Associated Glycoprotein / Q000008:administration & dosage / Q000276:immunology*; D063308:Myelin-Oligodendrocyte Glycoprotein; D009836:Oligodendroglia / Q000276:immunology; D010446:Peptide Fragments / Q000008:administration & dosage / Q000276:immunology*; D013154:Spleen / Q000737:chemistry / Q000166:cytology / Q000276:immunology
chemical_list: D003176:Complement C3; D016207:Cytokines; C571327:Mog protein, mouse; D009185:Myelin Proteins; D018992:Myelin-Associated Glycoprotein; D063308:Myelin-Oligodendrocyte Glycoprotein; D010446:Peptide Fragments; D018664:Interleukin-12